Publications by authors named "A B Alolayan"

To determine the prevalence of oral and maxillofacial lesions among patients at King Abdulaziz University from January 2016 to December 2022. : This cross-sectional observational study included patients diagnosed with oral and maxillofacial intra-bony lesions based on radiological findings and confirmed by histopathological examination. The lesions were classified according to the fourth edition of the World Health Organization Classification of Head and Neck Tumors.

View Article and Find Full Text PDF

Introduction: The prevalence of diet-related non-communicable diseases has increased. A low-carbohydrate diet (LCDs) is one of the most popular interventions. Several systematic reviews and meta-analyses of randomised clinical trials (RCTs) and non-RCTs have linked LCDs to the management of obesity, diabetes, cardiovascular disease, epilepsy, and cancer.

View Article and Find Full Text PDF

: Basal cell carcinoma is the most common nonmelanoma skin cancer, followed by cutaneous squamous cell carcinoma. The objective of the current study was to retrospectively evaluate the epidemiology, characteristic variations, histological aspects, and prognosis of basal cell carcinoma of the facial region based on a single-centre experience. : Data from 125 patients admitted to the Department of Oral and Maxillofacial Surgery, University Medical Center Schleswig-Holstein (UKSH), Kiel, for surgical treatment of basal cell carcinomas of the face between January 2015 and April 2021 were evaluated.

View Article and Find Full Text PDF
Article Synopsis
  • This study focused on metastatic renal cell carcinoma (mRCC), examining the survival outcomes of first-line immuno-oncological (ICI) regimens compared to single-agent tyrosine kinase inhibitors (TKIs) in Saudi Arabian patients.
  • A total of 84 patients diagnosed with clear cell mRCC were analyzed, showing a median progression-free survival (PFS) of 9.7 months and an overall survival (OS) of 42.0 months, with no significant difference between treatment groups.
  • The results indicated that first-line single-agent ICI therapy demonstrated promising anti-tumor activity and survival outcomes similar to both ICI-based combinations and TKIs, with liver metastasis and lower performance status being significant
View Article and Find Full Text PDF